Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients With IBD

GLP-1s are well tolerated and effective for weight loss in patients with IBD, according to new research

OCTOBER 31, 2024

Machine Learning Can Predict Best Responders to GLP-1s

Machine learning tools can sift through genetic profiles to predict which patients with obesity will best respond ...

SEPTEMBER 11, 2024

Expert Picks From DDW 2024, Part 1: IBD, EoE, NERD and More

In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, discusses five of her favorite abstracts and ...

JULY 12, 2024

Increased Constipation Risk Seen With Anti-Obesity Drugs, Particularly in Black Patients

The use of anti-obesity medications has increased in recent years, but few data exist on the effect of these ...

MAY 29, 2024

GLP-1RA Use Increases Gastric Food Retention Post-Endoscopy—But Fasting Mitigates This

Although patients appear more likely to retain stomach contents during endoscopic procedures,  this risk may ...

MAY 19, 2024

Treating Patients With Inflammatory Bowel Disease and Obesity

An estimated 41% of the US population is obese, including 22% of individuals aged 12 to 19 years, while nearly 1 of ...

MAY 10, 2024

ASHP Reports Drug Shortages Hit a 2-Decade High

The number of active, ongoing drug shortages has reached 323, the highest tally the American Society of ...

APRIL 25, 2024

Advances Usher In Era of Personalized Treatment for Obesity

The multifaceted, complex medical problem that is obesity is seeing big advances that are starting to have a major ...

JANUARY 15, 2024

New Study Links GLP-1 Agonists to Serious GI AEs

The popular drugs are associated with serious GI adverse effects such as pancreatitis, gastroparesis and bowel ...

DECEMBER 27, 2023